Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Do not store it at room temperature or freeze it
A recent human study presented at the Endocrine Society meeting found that obese men treated with GLP1 receptor agonists, including semaglutide, dulaglutide or tirzepatide, experienced a rise in normal testosterone levels from 53 percent to 77 percent over 18 months (closely correlated with weight loss), demonstrating how peptide-based therapies can effectively support and restore healthy testosterone production
A typical 5 mg vial reconstituted for subcutaneous injection lasts roughly 10 to 20 days depending on dose, meaning most patients need two to three vials per month 1
Strassels SA, Smith DH, Sullivan SD, Mahajan PS
